Trial record 1 of 99 for:    pediatric cancer grand rapids
Previous Study | Return to List | Next Study

Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Spectrum Health Hospitals
Sponsor:
Collaborators:
Van Andel Research Institute
Dell, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT01802567
First received: February 26, 2013
Last updated: February 5, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)